Effect of medication timing on anticoagulation stability in users of warfarin (the INRange RCT): study protocol for a randomized controlled trial

BACKGROUND: Warfarin is an oral anticoagulant medication that disrupts the liver’s production of clotting factors. While this medication is highly effective for the prevention of thromboembolic events, it also has a narrow therapeutic range and a vulnerability to interactions with other drugs and vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Heran, Balraj S., Allan, G. Michael, Green, Lee, Korownyk, Christina, Kolber, Michael, Olivier, Nicole, Flesher, Mary, Garrison, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973068/
https://www.ncbi.nlm.nih.gov/pubmed/27488365
http://dx.doi.org/10.1186/s13063-016-1516-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973068/
https://www.ncbi.nlm.nih.gov/pubmed/27488365
http://dx.doi.org/10.1186/s13063-016-1516-9

Ejemplares similares